Skip to main content

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler CodeLabeler NameOptional Effective Date (for State Coverage)Mandatory Effective Date (for State Coverage)
84670EVITA SOLUTIONS LLC08/07/202601/01/2027
87668ORPHAN THERAPIES LLC07/31/202610/01/2026
85776WELLHOUSE PHARMA, LLC07/31/202610/01/2026
87450HIGHMARK PHARMA LLC07/28/202610/01/2026
87528VICI PHARMACEUTICALS INC.07/28/202610/01/2026
85166VIRIDIAN THERAPEUTICS, INC.07/28/202610/01/2026
85052VERA THERAPEUTICS, INC.07/24/202610/01/2026
85866ORCA BIOSYSTEMS INC.07/17/202610/01/2026
87519ANVI PHARMACEUTICALS INC07/08/202610/01/2026
11788AIPING PHARMACEUTICALS, INC.06/04/202610/01/2026
85742KANCHAN HEALTHCARE INC.05/21/202610/01/2026
72303HEC PHARM USA INC.05/20/202610/01/2026
62993MOREPEN LABORATORIES LIMITED05/13/202610/01/2026
72874    GE HEALTHCARE INC.05/12/202610/01/2026
17156MEDI-PHYSICS INC. DBA GE HEALTHCARE05/12/202610/01/2026
70244SENTISS PHARMACEUTICALS LLC05/11/202610/01/2026
85972STELLON BIOTECH INC.05/07/202610/01/2026

Terminated Labelers

Labeler CodeLabeler NameEffective Date
25208MEDICURE INTERNATIONAL, INC.10/01/2026
00007GLAXOSMITHKLINE LLC10/01/2026
55670MOORE MEDICAL10/01/2026
83035SINGULAR DREAMER, LTD10/01/2026

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on August 10, 2026